Israel Corp (ILCO) AI Stock Analysis

• Market Cap: 7.82B
• Dividend Yield: 0.67%
• Average Volume (3M): 11.37K
• Price to Earnings (P/E): 13.5
• Beta (1Y): 1.33
• Revenue Growth: -3.57%
• EPS Growth: -20.25%
• Country: IL
• Employees: 13,067
• Sector: Basic Materials
• Sector Strength: 57
• Industry: Chemicals - Specialty
• EPS (TTM): 2051.40
• Shares Outstanding: 7,572,548
• 10 Day Avg. Volume: 16,496
• 30 Day Avg. Volume: 11,366
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: 118,477.03
• Price Target Upside: 13.65% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 62 Neutral
• Price Target: 118,476 ▲(13.65% Upside)

Israel Corp's overall stock score reflects sound financial health with stable operational margins and effective cash management. While the valuation suggests potential undervaluation, the technical analysis indicates bearish momentum. The lack of dividend attractiveness and challenges in revenue growth weigh on the overall score.

Israel Corp Business Overview & Revenue Model

Company Description

Israel Corp (ILCO) is a prominent holding company based in Israel, primarily engaged in the management of a diverse range of industrial and commercial enterprises. The company focuses on key sectors including chemicals, energy, shipping, transportation, and technology. Israel Corp operates through its subsidiaries, offering products and services that range from specialty chemicals and fertilizers to shipping and transportation solutions, as well as investments in innovative technology ventures.

How the Company Makes Money

Israel Corp makes money through its diversified portfolio of subsidiaries and investments across various industries. The company generates revenue from the sale of specialty chemicals and fertilizers through its chemical subsidiaries, such as Israel Chemicals Ltd. (ICL). In the energy sector, Israel Corp benefits from its stakes in power generation and energy distribution businesses. The shipping and transportation sector contributes to the company's earnings through its ownership in major shipping lines and logistics services. Additionally, Israel Corp invests in technology companies, leveraging strategic partnerships and venture capital to drive growth and returns. The company's revenue streams are further bolstered by its global presence and ability to capitalize on emerging market opportunities.

Israel Corp Financial Statement Overview

Summary

Israel Corp displays sound financial health with stable operational margins and effective cash flow management. The company maintains a strong balance sheet with low leverage. However, opportunities exist to improve net profit margins and return on equity.

Income Statement

The company shows a steady gross profit margin at around 32.8% for TTM, indicating a stable cost management. However, the net profit margin for the TTM is relatively low at 2.4%, reflecting pressure on bottom-line profitability. Revenue growth has been inconsistent, with a significant decline in 2022 and a modest recovery thereafter. EBIT and EBITDA margins are stable at 10.8% and 20.5% respectively for TTM, showing consistent operational efficiency.

Balance Sheet

The balance sheet reflects a strong equity position with an equity ratio of 22.3% for TTM, indicating a decent level of financial stability. The debt-to-equity ratio stands at 0.27, showing effective leverage management. Return on equity is moderate, at 5.7% for TTM, suggesting room for improvement in generating returns on shareholder investments.

Cash Flow

The cash flow position is robust, with a strong operating cash flow to net income ratio of 8.0 for TTM, indicating excellent cash generation relative to reported earnings. Free cash flow has shown variability but is positive, with a slight decline in the most recent period. The free cash flow to net income ratio is high at 3.34, reflecting strong cash flow performance relative to earnings.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	6.84B	7.54B	10.02B	6.96B	5.04B
Gross Profit	2.25B	2.67B	5.03B	2.61B	1.49B
EBITDA	1.43B	1.71B	4.06B	1.93B	711.00M
Net Income	190.00M	273.00M	953.00M	88.00M	-173.00M
Balance Sheet
Total Assets	12.49B	12.89B	13.09B	12.26B	11.08B
Cash, Cash Equivalents and Short-Term Investments	1.32B	1.57B	1.56B	1.14B	1.06B
Total Debt	604.00M	1.05B	3.96B	4.61B	4.44B
Total Liabilities	6.11B	6.53B	7.24B	7.98B	7.32B
Stockholders Equity	2.82B	2.78B	2.46B	1.54B	1.40B
Cash Flow
Free Cash Flow	710.00M	1.04B	1.46B	497.00M	290.00M
Operating Cash Flow	1.42B	1.82B	2.21B	1.11B	917.00M
Investing Cash Flow	-343.00M	-1.10B	-748.00M	-830.00M	-398.00M
Financing Cash Flow	-979.00M	-931.00M	-1.16B	-403.00M	-192.00M

Israel Corp Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 104250.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:ILCO, the sentiment is Negative. The current price of 104250 is below the 20-day moving average (MA) of 107193.00, below the 50-day MA of 111768.60, and below the 200-day MA of 104592.20, indicating a bearish trend. The MACD of -2791.17 indicates Positive momentum. The RSI at 39.41 is Neutral, neither overbought nor oversold. The STOCH value of 57.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:ILCO.

Israel Corp Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
KAFR	80 Outperform	661.93M	9.78		2.88%	15.45%	26.50%
POLP	73 Outperform	1.23B	13.96		3.27%	1.43%	-0.59%
RIMO	72 Outperform	432.46M	10.36		9.93%	-10.12%	5.34%
TRPZ	70 Outperform	5.06B	84.03		0.60%	54.19%	28.29%
ILCO	62 Neutral	7.82B	13.55	5.48%	0.67%	-3.57%	-20.25%
Sector *	61 Neutral	$10.11B	6.10	1.13%	3.03%	2.99%	-45.49%

Israel Corp Corporate Events

Israel Corp Clarifies Director’s Involvement in Unrelated Legal Matter

Israel Corp has announced that a statement of claims has been filed against Mr. Yaakov Amidror, an external director at the company, by the Securities Authority. This is in relation to his role as chairman of the board at Next Gen Biomed Ltd. The company clarified that it has no connection to Next Gen Biomed Ltd or the ongoing administrative enforcement procedure.